Market revenue in 2023 | USD 1,389.6 million |
Market revenue in 2030 | USD 2,194.5 million |
Growth rate | 6.7% (CAGR from 2023 to 2030) |
Largest segment | Tsh test |
Fastest growing segment | TSH Test |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | TSH Test, T4 Test, T3 Test, Free T4 Test, Free T3 Test |
Key market players worldwide | Quest Diagnostics Inc, Labcorp Holdings Inc, Everly Health, Palomar Holdings Inc, Neuberg Diagnostics, Thyrocare Technologies, Ulta Lab Tests, DHA Laboratory, ZRT Laboratory, LifeLabs |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to thyroid function testing market will help companies and investors design strategic landscapes.
Tsh test was the largest segment with a revenue share of 42.89% in 2023. Horizon Databook has segmented the Europe thyroid function testing market based on tsh test, t4 test, t3 test, free t4 test, free t3 test covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe thyroid function testing market , including forecasts for subscribers. This continent databook contains high-level insights into Europe thyroid function testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account